Stallion India Fluorochemicals Ltd (STALLION) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Stallion India Fluorochemicals Ltd on NSE and BSE, with an AI summary of each filing.
Intimation of Revised Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation · 04 Nov 2026, 2:14 am
Stallion India Fluorochemicals Reschedules Investor Meeting to 6th Nov'26 Stallion India Fluorochemicals Limited has revised the schedule for its management interaction with investor Mr. Ajay Upadhyaya. The virtual meeting, originally slated for 3rd Nov'26, is now rescheduled to Friday, 6th Nov'26, at 3:30 PM IST. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction.
Intimation of Analyst/Investor Meeting on 3rd November 2026
Intimation · 31 Oct 2026, 12:06 am
Stallion India Fluorochemicals Schedules Investor Meeting for 3rd Nov'26 Stallion India Fluorochemicals Limited informed stock exchanges, pursuant to Regulation 30(6) of SEBI LODR Regulations, that its management is scheduled to hold a virtual analyst/investor meeting with Mr. Ajay Upadhyaya on Tuesday, 3rd Nov'26, from 3:30 PM to 4:30 PM IST. The company confirmed that no unpublished price sensitive information (UPSI) will be discussed during the interaction, and any schedule changes due to exigencies will be updated with the exchanges.
Intimation of Schedule of Analyst/Investor Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation · 17 Oct 2026, 12:55 am
Stallion India Fluorochemicals Schedules Institutional Investor Meetings Stallion India Fluorochemicals Limited has scheduled interactions with institutional analysts and investors under SEBI Listing Regulations. The management will conduct an in-person meeting with ICICI Securities on 21st Oct'26 at 4:00 PM IST. On 22nd Oct'26, the company will host a virtual group meeting with Kotak Securities from 3:00 PM to 4:00 PM IST, followed by a virtual meeting with Nuvama Wealth Management at 4:30 PM IST. No unpublished price-sensitive information will be shared during these interactions.
As per the attachment
Others (Uncategorized) · 15 Oct 2026, 11:42 pm
Maharashtra GST Authorities Conclude Search at Stallion India Fluorochemicals Maharashtra State GST officials conducted an inspection and search at Stallion India Fluorochemicals Limited’s Mumbai office from 9th Oct'26 to 14th Oct'26. The investigation identified Input Tax Credit (ITC) discrepancies, including inadmissible ITC on OFS expenses, blocked credits, cancelled suppliers, and ISD allocation issues. The company completed all voluntary compliances, reversals, and paid the communicated tax and interest liabilities. Management noted that most rectifications are revenue-neutral, expecting no material impact on ongoing business operations or financials.
As per the attachment
Intimation · 29 Sept 2026, 9:03 pm
Stallion India Fluorochemicals Revises Investor Meeting Schedule to In-Person Format Stallion India Fluorochemicals Limited revised the format of its investor meetings scheduled for 1st Oct'26 from a group virtual meet to individual in-person sessions. The management is scheduled to meet Aditya Birla Sun Life Mutual Fund at 03:30 PM IST, OHM Capital at 04:40 PM IST, and Ambit Asset Management at 05:30 PM IST. The company confirmed that no unpublished price-sensitive information will be discussed during these interactions.
Schedule of Group Virtual Meet with the Analyst/Investor Meeting to be held on Thursday, 01st October, 2026 at 04:00 PM (IST).
Intimation · 29 Sept 2026, 12:17 am
Stallion India Fluorochemicals Schedules Group Analyst and Investor Meeting Stallion India Fluorochemicals Limited announced a group virtual meeting with institutional investors scheduled for 1st Oct'26 at 4:00 PM IST. Participating institutions include Aditya Birla Sun Life Mutual Fund, OHM Capital, and Ambit Asset Management. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction.
As per the attachment.
Annual General Meeting · 22 Sept 2026, 11:27 pm
Stallion India Fluorochemicals Approves Key AGM Resolutions with Overwhelming Majority Stallion India Fluorochemicals Limited announced that shareholders approved all three proposed resolutions at its 24th AGM held on 21st Sep'26 with requisite majorities. Key approvals include the adoption of FY26 financial statements (99.9986% votes in favour), the reappointment of Mrs. Manisha Shazad Rustomji as Director retiring by rotation (99.9939% votes in favour), and the appointment of Ms. Swati Ghosh as Independent Director via special resolution (99.9879% votes in favour). Remote and AGM e-voting covered 71,745,061 total votes cast across eligible shareholding.
As per the attachment
Annual General Meeting · 22 Sept 2026, 12:41 am
Stallion India Fluorochemicals Concludes 24th Annual General Meeting Stallion India Fluorochemicals Limited conducted its 24th AGM on 21st Sep'26 via video conferencing with 34 members attending. Key agenda items transacted included the adoption of audited financial statements for FY26 ended 31st Mar'26, the reappointment of Mrs. Manisha Shazad Rustomji as a Director retiring by rotation, and the appointment of Ms. Swati Ghosh as Woman Independent Director. Chairman & MD Shazad Sheriar Rustomji outlined forward-looking business plans. Voting results and the consolidated scrutinizer report will be submitted separately upon formal declaration.
As per the attachment
Others (Uncategorized) · 20 Sept 2026, 12:07 am
Stallion India Fluorochemicals Commences Commercial Operations at Khalapur Specialty Gas Facility Stallion India Fluorochemicals has commenced commercial operations at its Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra, effective 21st Sep'26. The plant features an aggregate installed capacity of 1,200 MT per annum, handling specialty gases, cryogenic containers, and ISO tanks. Funded via IPO proceeds per its 21st Jan'26 prospectus, the facility marks the company's strategic entry into high-margin semiconductor gases, diversifying its product portfolio and expanding overall production capacity to drive forward revenue growth.
Schedule of Analyst/Investor Meeting to be held on 08th September, 2026.
Intimation · 05 Sept 2026, 1:02 am
Stallion India Fluorochemicals Schedules Investor Meeting with Canara HSBC Life Insurance Stallion India Fluorochemicals Ltd has scheduled a virtual management meeting with Canara HSBC Life Insurance on 8th Sep'26, pursuant to Regulation 30 of the SEBI LODR Regulations. The meeting will be hosted virtually from the company's registered office. The management confirmed that no unpublished price-sensitive information (UPSI) will be discussed during the interaction.
Annual Report for the Financial Year 2025-26
Others (Uncategorized) · 30 Aug 2026, 4:53 am
As per the attachment
Annual General Meeting · 30 Aug 2026, 1:21 am
Stallion India Sets 24th AGM and Key Resolutions Stallion India Fluorochemicals will hold its 24th AGM via video conference on 21st Sep'26. The cut-off date for e-voting eligibility is 16th Sep'26, with the remote e-voting window open from 17th Sep'26 to 20th Sep'26. Key agenda items include adopting financial statements for the year ended 31st Mar'26, the re-appointment of director Mrs. Manisha Shazad Rustomji, and the appointment of Ms. Swati Ghosh as an Independent Director for a five-year term effective 13th May'26.
Transcript of the Investor Conference with regard to the business and financial performance of the Company for the quarter ended 30th June, 2026.
Transcript · 20 Aug 2026, 8:58 pm
Stallion Q1 FY27: Strong Profitability, Capacity Expansion Underway Stallion India Fluorochemicals reported strong Q1 FY27 results, with revenue at ₹124.68 Cr (+12.78% YoY), EBITDA at ₹25.27 Cr (+75.85% YoY), and PAT at ₹18.57 Cr (+79.15% YoY). Management highlighted profitability improvement from a better product mix and planning. Key projects are progressing: the Khalapur helium plant (1200 MTPA) will start commercial operations in the coming quarter, and the Bhilwara R32 plant (10,000 MTPA) is targeted for completion by Dec'26. Guidance remains for 30-35% revenue CAGR and 3-4% EBITDA margin expansion over the medium term.
As per the attachment
Others (Uncategorized) · 19 Aug 2026, 2:16 am
Stallion India: Q1FY27 Rights Issue Fund Utilization & Project Update Stallion India Fluorochemicals utilized ₹117.83 Cr in Q1FY27 from its ₹363.93 Cr rights issue, bringing total utilization to ₹192.91 Cr as of 30 Jun'26. An unutilized balance of ₹171.02 Cr remains, primarily held in bank fixed deposits. The construction of the manufacturing facility is delayed by four months to Nov'26 due to design changes. For this project, ₹113.61 Cr was spent in the quarter, with major payments being advances to EPC contractor Pansen Engineering. Project costs remain unchanged. No deviations in fund use were reported.
Audio Recording of the Earnings Conference Call held on 17th August, 2026 to discuss the Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026.
Audio / Video · 18 Aug 2026, 6:19 pm
Stallion Provides Audio Recording for Q1 FY27 Earnings Call Stallion India Fluorochemicals (NSE: STALLION) has released the audio recording of its earnings conference call held on 17th Aug'26. The call discussed the unaudited financial results for the quarter ended 30th Jun'26. As per the regulatory filing on 18th Aug'26, the recording is now accessible on the company's investor relations website. This provides further details and management commentary on the company's performance for the first quarter of the fiscal year.
Investor Presentation for the Financial Results for the Quarter ended on 30th June, 2026.
Investor Presentation · 15 Aug 2026, 1:48 am
Stallion Fluorochemicals: Expansion and Margin Improvement Driving Growth Stallion reported robust Q1 FY27 results with revenue at ₹124.68 Cr (+12.78% YoY) and PAT at ₹18.57 Cr (+79.15% YoY). EBITDA margins improved to 20.27% from 13% YoY. Key growth drivers include strategic expansion into high-purity helium and next-gen HFO refrigerants. The company's new 10,000 MT R-32 plant in Bhilwara, expected to commission by Oct'26, strengthens backward integration. This plant is projected to add ₹250 Cr topline in FY27 and has an expected PAT margin of 22-24%, signaling significant profitability enhancement.
Press release titled " Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to Rs. 18.59 Crore"
Press Release · 15 Aug 2026, 1:29 am
Stallion India Reports Strong Q1 FY27; PAT Jumps 79% YoY on Margin Expansion Stallion India Fluorochemicals reported strong Q1 FY27 results with PAT surging 79.15% YoY to ₹18.57 crore. Total revenue grew 12.78% YoY to ₹124.68 crore, while EBITDA increased 75.85% to ₹25.27 crore, reflecting significant margin improvement. Management reiterated its guidance for 30-35% revenue CAGR over the next three years, with a 3-4% EBITDA margin expansion expected from backward integration. Key projects, including the 1,200 MTPA Khalapur helium facility and the 10,000 MTPA Bhilwara R-32 plant, are progressing as planned.
Monitoring Agency Report for the quarter ended on 30th June, 2026 with respect to the utilisation of proceeds of the IPO.
Others (Uncategorized) · 15 Aug 2026, 12:25 am
Stallion India Fluorochemicals: IPO Proceeds Utilization Report for Q1FY27 Stallion India Fluorochemicals submitted its IPO proceeds utilization report for the quarter ended 30th Jun'26. Per a special resolution on 03rd Jun'26, the company revised IPO object costs and timelines. The allocation for 'issue expenses' increased from ₹11.99 crore to ₹15.98 crore. Capex for the Khalapur facility was altered, replacing warehouse construction (₹7.67 crore) with land purchase (₹7.80 crore). As of quarter-end, ₹155.72 crore of the ₹160.73 crore IPO proceeds have been utilized, with ₹9.14 crore spent on the Khalapur facility during the quarter.
Intimation regarding Q1 FY 2026-27 Earnings Call.
Intimation · 17 Aug 2026, 4:00 pm
Stallion Announces Q1 FY27 Earnings Call Details Stallion India Fluorochemicals Ltd. will host a conference call on Mon, 17th Aug'26, at 4:00 PM IST to discuss its financial results for the quarter ended 30th Jun'26. The call will be led by Mr. Shazad Rustomji, Managing Director & CEO. The event will be held via Zoom, and prior registration is required for participation. The company's NSE symbol is STALLION and its BSE scrip code is 544342. This intimation is pursuant to Regulation 30 of SEBI Listing Regulations.
Outcome of Board Meeting held on 12th August, 2026
Outcome · 12 Aug 2026, 6:57 pm
Stallion India Reports Strong Q1FY27 Results and Announces AGM Details Stallion India Fluorochemicals reported strong Q1FY27 results, with revenue from operations at ₹12,144.60 crore, up 9.9% YoY. Profit after tax grew 79.2% YoY to ₹1,856.58 crore. Sequentially, PAT increased by 69.8% QoQ despite a 21.8% QoQ decline in raw material costs. The board has scheduled the AGM for 21st Sep'26, with a book closure from 15th Sep'26 to 21st Sep'26. The auditor's review report on the financials carried an unmodified opinion. The board also approved the regularization of Ms. Swati Ghosh as an Independent Director.
Intimation of Schedule of Analyst/Investor Meeting pursuant to be held on Tuesday, 21st July, 2026.
Intimation · 16 Jul 2026, 4:11 pm
Stallion India Fluorochemicals Schedules Virtual Group Investor Meeting Stallion India Fluorochemicals has scheduled a virtual group meeting with analysts and investors for 21st Jul'26. Key participants include Barclays Wealth, ICICI Securities, Nuvama Wealth Management, and IIFL Securities. Other attendees listed are Ambit PMS, Elios Financial, VentureX Alpha AMC, Dempo Family Office, Moneybee PMS, and Svan Investments. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed. The meeting schedule is subject to change.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neomile Corporate Advisory Ltd & Neomile Growth ....
Acquisition/ Disposal of Shares · 05 Jun 2026, 9:44 pm
Neomile Asset Managers Reduces Stake in Stallion India Fluorochemicals Neomile Asset Managers, along with persons acting in concert, disclosed a significant stake reduction in Stallion India Fluorochemicals (STALLION). Between 1st Jun'26 and 4th Jun'26, the group sold 29,33,472 shares, equivalent to 2.53% of the company's voting capital, through open market transactions. This sale decreased their total holding from 1,43,83,538 shares (12.39%) to 1,14,50,066 shares (9.86%). The disclosure was filed under SEBI's Substantial Acquisition of Shares and Takeovers Regulations on 5th Jun'26.
Transcript of the Investor Conference for the business and financial performance of the Company for the Quarter & Financial Year ended on 31st March, 2026.
Transcript · 23 May 2026, 12:12 am
Stallion India Fluorochemicals FY26 Results and Growth Outlook Stallion India Fluorochemicals reported FY26 revenue of INR 434.12 Cr (+14.4% YoY) and PAT of INR 43.84 Cr (+35.61% YoY), surpassing its guidance. The company is targeting 30-35% revenue CAGR for the next three years, driven by major capacity expansions. Its 10,000 MT R-32 manufacturing facility in Bhilwara is expected to commence production by Oct'26, boosting margins. The Mumbattu and Khalapur facilities are also set to go online by Aug'26. For FY27, management projects PAT could reach ~INR 100 Cr.
As per the attachment.
Others (Uncategorized) · 19 May 2026, 11:41 pm
Stallion Fluorochemicals Flags Material Deviation in IPO Proceeds Utilization for Q4FY26 CARE Ratings' monitoring report for the quarter ended 31st Mar'26 highlights material deviations in Stallion India Fluorochemicals' Rs.160.73 Cr IPO proceeds utilization. Total overutilization is Rs.7.71 Cr, primarily from excess spending of Rs.3.99 Cr on issue expenses and Rs.3.71 Cr on working capital. The company exceeded the prospectus budget for issue expenses by 33%, spending Rs.15.99 Cr against a planned Rs.11.99 Cr. Delays were also noted in capex projects. Shareholder approval for these deviations is currently underway via e-vote.
As per the attachment.
Audio / Video · 19 May 2026, 4:34 pm
Stallion Publishes Earnings Call Recording for Q4 & FY26 Stallion India Fluorochemicals Ltd. has released the audio recording of its earnings conference call, held on 18th May'26. The call discussed the audited financial results for the fourth quarter and the full financial year ended 31st Mar'26. The recording is accessible via a provided link, as per the company's disclosure to the NSE and BSE exchanges dated 19th May'26. This follows the company's regulatory compliance under SEBI's Listing Obligations and Disclosure Requirements regulations.